inflection_biosciences_logo_2015 transpa
  • ABOUT US

    • TEAM
    • DIRECTORS
    • ADVISORS
    • CAREERS
  • WHAT WE DO

    • PIPELINE
    • TECHNOLOGY
    • IBL-101
    • IBL-202
    • AUM302
  • NEWS

    • PRESS RELEASES
    • IN THE NEWS
    • PUBLICATIONS
  • PARTNERSHIPS

    • IN-LICENSING
    • OUT-LICENSING
  • CONTACT US

  • More

    Use tab to navigate through the menu items.

    News

    Press Releases
    In The News
    Publications

    In The News

    • Proactive interview with Inflection Biosciences CEO, Darren Cunningham, during the BIO CEO & Investor Conference, NYC, February 2020.
       

    • SiliconRepublic interview with Inflection Biosciences CEO, Darren Cunningham, as part of European Biotech Week - September 2017.

    ​

    • Pharmaboardroom.com interview with Inflection Biosciences CEO, Darren Cunningham, as part of their Country Report on Ireland - November 2016.

    ​

    • ecancertv: Dr. Giles Best, Kolling Institute of Medical Research, University of Sydney, discusses the potential for IBL-202 in chronic lymphocytic leukaemia (CLL) - September 2015.
       

    • Business Plus: Feature on Inflection Biosciences - December 2014.
       

    • BioCentury: Emerging Company Profile - Pairing up PIM - July 29, 2013.

    ​

    • 'Drug Discovery with Strong Inflection'; DDN News - July 2013.

    ​

    • The Sunday Business Post 'Start up of the Day': Inflection Biosciences - July 5, 2013.

    ​

    • The Sunday Business Post Done Deal: Inflection Biosciences - June 9, 2013.

    ​

    • The Irish Independent: Inflection Biosciences- June 4, 2013.

    ​

    • Darren Cunningham, CEO of Inflection Biosciences, interviewed on Morning Ireland Radio in connection with Inflection Biosciences’ license agreement with CNIO - June 4, 2013.

    ​

    • Darren Cunningham, CEO of Inflection Biosciences, interviewed on national television in connection with Inflection Biosciences’ license agreement with CNIO – June 4, 2013.

    inflection_biosciences_logo_2015%20trans

    Disclaimer   Copyright    Privacy Policy

    OUR COMPANY

    TEAM

    DIRECTORS

    ADVISORS

    CAREERS

    WHAT WE DO

    PIPELINE

    TECHNOLOGY

    IBL-101

    IBL-202
    AUM302

    NEWS

    PRESS RELEASES

    IN THE NEWS

    PUBLICATIONS

    PARTNERSHIPS

    IN-LICENSING

    OUT-LICENSING

    CONTACT US

    4 Logos with Text.png

    FOLLOW US

    • Twitter
    • LinkedIn Social Icon

    Copyright © 2012-2020 Inflection Biosciences, Inc. All Rights Reserved

    EITH_EU_White_V_ .png